E02A0019 Rat Androgen ELISA kit
Rat Androgen ELISA kit is suitable for the detection of samples from Rat species. Androgen can also be called ADG.
E02A0019 Rat Androgen ELISA kit
Rat Androgen ELISA kit is suitable for the detection of samples from Rat species. Androgen can also be called ADG.
Product Information | |
Cat. No. | E02A0019 |
Product Name | Rat Androgen ELISA kit |
Species | Rat |
Product Size | 48 Tests / 96 Tests |
Concentration | 0.5-10ng/ml |
Sensitivity | 0.1 ng/mL |
Principal | Competitive ELISA |
Sample Volume | 100 ul |
Sample Type | Serum, plasma, cell culture supernatants, body fluid and tissue homogenate |
Assay Time | 90 minutes |
Platform | Microplate Reader |
Conjugate | HRP |
Detection Method | Colorimetric |
Storage | 2-8°C |
Kit Components | ||
MATERIALS | SPECIFICATION | QUANTITY |
MICROTITER PLATE | 96 wells | stripwell |
ENZYME CONJUGATE | 6.0 mL | 1 vial |
STANDARD A (0.5mL) | 0 ng/mL | 1 vial |
STANDARD B (0.5mL) | 0.5 ng/mL | 1 vial |
STANDARD C (0.5mL) | 1.0 ng/mL | 1 vial |
STANDARD D (0.5mL) | 2.5 ng/mL | 1 vial |
STANDARD E (0.5mL) | 5.0 ng/mL | 1 vial |
STANDARD F (0.5mL) | 10 ng/mL | 1 vial |
SUBSTRATE A | 6 mL | 1 vial |
SUBSTRATE B | 6 mL | 1 vial |
STOP SOLUTION | 6 mL | 1 vial |
WASH SOLUTION (100 x) | 10 mL | 1 vial |
BALANCE SOLUTION | 3 mL | 1 vial |
Principle of the Assay |
ADG ELISA kit applies the competitive enzyme immunoassay technique utilizing an anti-ADG antibody and an ADG-HRP conjugate. The assay sample and buffer are incubated together with ADG-HRP conjugate in pre-coated plate for one hour. After the incubation period, the wells are decanted and washed five times. The wells are then incubated with a substrate for HRP enzyme. The product of the enzyme-substrate reaction forms a blue colored complex. Finally, a stop solution is added to stop the reaction, which will then turn the solution yellow. The intensity of color is measured spectrophotometrically at 450nm in a microplate reader. The intensity of the color is inversely proportional to the ADG concentration since ADG from samples and ADG-HRP conjugate compete for the anti-ADG antibody binding site. Since the number of sites is limited, as more sites are occupied by ADG from the sample, fewer sites are left to bind ADG-HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The ADG concentration in each sample is interpolated from this standard curve. |
Coefficient of Variance | Intra Variation% <10% | |
Inter Variation% <12% | ||
Recovery | 95-107% | |
Linearity | Diluent Ratio | Range % |
1:2 | 93-102 | |
1:4 | 90-106 | |
1:8 | 90-109 | |
Specificity/Cross-reactivity | No significant cross-reactivity or interference between ADG and analogues was observed. |
E02A0019 has been referenced in the below publications:
GFW Modified act on Polycystic Ovary Syndrome in ExPerimental and Clinical Efficacy of Phlegm and blood stasis type.
Related Bluegene Biotech Products
BlueGene Biotech News